G8 Heiligendaam Summit Declaration on Growth and Responsibility in Africa

Sectors : General health and health funding, HIV/AIDS, Malaria, TB, Maternal health, reproductive health and infant mortality, Health systems, medicines and regulation, Labour migration, Polio, Gender and social development, International trade: market access, subsidies and aid for trade, Health and technology
Organisation : G8
Date made: 
2007
You are viewing a filtered list of commitments, click here to view all commitments in this text

Commitments in: Health - General health and health funding

“...49. G8 members pledge to work with other donors to replenish the GFATM and to provide long-term predictable funding based on ambitious, but realistic demand-driven targets...G8 partners will work with other stakeholders so that Global Fund resources continue to be used in alignment with existing national priorities and processes.”

Scope: 
Africa

“59. In view of the G8 countries contributions to achieving the health related international goals we agreed in St. Petersburg to review the progress in this regard, including our financial commitments, in fighting the three diseases HIV/AIDS, tuberculosis and malaria, regularly. We will undertake this monitoring exercise for the first time this year under the Presidency’s guidance. The report will inform our activities and commitments and we affirm that we will continue this close monitoring process regularly.”

Scope: 
Africa

Commitments in: Health - Maternal health, reproductive health and infant mortality

“50. …In the overall context of scaling up towards the goal of universal access and strengthening of health systems we will contribute substantially with other donors to work towards the goal of providing universal coverage of PMTCT programs by 2010…The G8 together with other donors will work towards meeting the needed resources for paediatric treatments in the context of universal access, at a cost of US$ 1,8 billion till 2010, estimated by UNICEF. We will also scale up efforts to reduce the gaps, in the area of maternal and child health care and voluntary family planning, an estimated US$ 1,5 billion.”

Scope: 
Africa

Commitments in: Health - Health systems, medicines and regulation

“56. We will support responding to those African countries that indicate that they require technical assistance and capacity building programmes for advancing their access to affordable, safe, effective and high quality generic and innovative medicines in a manner consistent with the WTO. The G8 reiterate their support for the work of WHO including its prequalification program and for regulatory authorities to help assure the safety, efficacy, and quality of pharmaceutical drugs, including those produced locally, in particular for second-line antiretroviral treatment and for the newly developed more effective treatment for malaria."

Scope: 
Africa

“63. …We will work with African states to address the different causes of this lack of human resource capacity within the health sector, including working conditions and salaries with the aim of recruiting, training and retaining additional health workers. We will also work with national governments as they endeavor to create an environment where its most capable citizens, including medical doctors and other healthcare workers, see a long-term future in their own countries. Furthermore, we will work with the Global Health Workforce Alliance, interested private parties, the OECD and the WHO to build the evidence base on health workforce management and international migration.”

Scope: 
Africa

Commitments in: Health - Polio

“54. …The G8 will make utmost efforts in cooperation with international organizations and partners to eradicate polio and will also work with others to close urgent funding shortfalls.”

Scope: 
Africa

Commitments in: Health - Malaria

“55. …the G8 are committed to expand significantly their efforts to contributing to meet the Millennium Development Goal of having halted and begun to reverse the scourge of malaria. To this effect, we will work with African governments and donors to strengthen the effectiveness of their malaria control programs in Africa along the three main intervention lines of artemisinin combination therapy, effective case management, effective, tailored vector control strategies and bednets…G8 members, in support of national malaria control programs, using existing and additional funds, will individually and collectively over the next few years work to enable the 30 highest malaria prevalence countries in Africa (contributing to at least 80 percent of the global malaria deaths) reach at least 85 percent coverage of the most vulnerable groups with effective prevention and treatment measures and achieve a 50 percent reduction in malaria related deaths. To accelerate implementation of the financial commitments we have undertaken at Gleneagles we will work to reach this goal by mobilizing the private sector and its expertise and resources, enhancing public awareness, encouraging public-private partnerships, and urging non-G8 countries to do the same…”

Scope: 
Africa

Commitments in: Health - HIV/AIDS

“48. The G8 countries will scale up their efforts to contributing towards the goal of universal access to comprehensive HIV/AIDS prevention programs, treatment and care and support by 2010 for all, and to developing and strengthening health systems so that health care, especially primary health care, can be provided on a sustainable and equitable basis in order to reduce illness and mortality, with particular attention paid to the needs of those most vulnerable to infection, including adolescent girls, women and children…We will continue our efforts towards these goals to provide at least a projected US$ 60 billion over the coming years, and invite other donors to contribute as well...”

Scope: 
Africa

“50. Recognizing the growing feminization of the AIDS epidemic, the G8 in cooperation with partner governments support a gender-sensitive response by the GFATM, with the goal of ensuring that greater attention and appropriate resources are allocated by the Fund to HIV/AIDS prevention, treatment, and care that addresses the needs of women and girls…”

Scope: 
Africa

“51. …The G8 will take concrete steps to support education programs especially for girls, to promote knowledge about sexuality and reproductive health and the prevention of sexually transmitted infections. The G8 will support the nationwide inclusion of appropriate HIV/AIDS-related information and life-skills information in school curricula, in the context of nationally owned sector plans as well as prevention information with regard to malaria and other relevant health topics.

52. The G8 will emphasize the importance of programs to promote and protect human rights of women and girls as well as the prevention of sexual violence and coercion especially in the context of preventing HIV/AIDS infections. We welcome the commitment expressed by African partners aiming at promoting the rights and role of women and girls. We will also work to support additional concerted efforts to stop sexual exploitation and gender-based violence.”

Scope: 
Africa

“53. The G8 will take concrete steps to work toward improving the link between HIV/AIDS activities and sexual and reproductive health and voluntary family planning programs, to improve access to health care, including preventing mother-to-child trans-mission, and to achieve the Millennium Development Goals by adopting a multisectoral approach and by fostering community involvement and participation.”

Scope: 
Africa

“54. We are committed to working toward further integration of efforts against TB and HIV/AIDS and the integration of DOTS-treatment and other comprehensive approaches necessary to control TB in our programs and activities in order to alleviate the burden of the co-pandemic…”

Scope: 
Africa

“57. The G8 reaffirm their commitment to scaling up towards “universal access” to comprehensive HIV prevention, treatment and care by 2010…We will therefore work with UNAIDS, WHO, WB and the GF to strengthen their efforts and work together with the African Union and African States, the innovative and generic pharmaceutical industry, private donors, civil society and other relevant stakeholders to help deliver next steps towards “universal access”…In particular we will work with:

African Governments

• to strengthen and finance health systems and make them more efficient with con-structive support of donors and the relevant international organizations such as WHO and World Bank,

• to contribute to the provision of affordable and quality medicines by eliminating or substantially reducing import tariffs and taxes with the aim to exempt price-reduced or subsidised medicines from these levies as soon as possible and examining logistics and governance issues that may hinder access,

• to strengthen procurement practices, ensuring accountability and transparency and to review the currently existing drug and device registration policies with the aim of facilitating timely access to safe, affordable and effective HIV/AIDS drugs and medical devices,

• to develop country-led policies that can ensure effective coordination of donor health programs and identify technical assistance needs, with the support of the WHO, World Bank, UNAIDS, GFATM and other agencies.

International Organizations and donors

• to support country-led efforts to improve coordination between all relevant stake-holders to develop costed, inclusive, sustainable, credible and evidence-based national AIDS plans which ensure effective links to health system strengthening,

• to intensify their efforts to assist countries in setting up a workable forecasting system for pharmaceutical demand,

• to respond constructively to requests by African developing countries without manufacturing capacities with regard to the use of the flexibilities referenced in the WTO Doha declaration on TRIPS and Public Health, while respecting WTO obligations,

• to continue to support investments in research and development of new medi-cines, microbicides and vaccines, including by promoting policies that encourage innovation.

The Pharmaceutical Industry

• to continue to explore further initiatives to provide enhanced access to HIV-medicines at affordable prices and to review price policies with regard to second-line antiretroviral drugs.

• to consider supporting local production of HIV/AIDS pharmaceuticals by voluntary licences and laboratory capacities that meet international standards and strengthen regulatory, certification and training institutes.

• to build on their expressed commitment to increase investment in research and development of new medicines, microbicides and vaccines also by extending public-private partnership.”

Scope: 
Africa

“58. As an important step to scaling up towards the goal of universal access to HIV/AIDS prevention, treatment, care and support in Africa, G8 members, in support of national HIV/AIDS programs globally, individually and collectively over the next few years will aim to employ existing and additional programs to support life-saving anti-retroviral treatment through bilateral and multilateral efforts for approximately five million people, to prevent twenty-four million new infections, and to care for twenty-four million people, including ten million orphans and vulnerable children.”

Scope: 
Africa